We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

How an Interest in Bipolar Disorder Drugs Led to a Better Understanding of Leukemia

News   Nov 01, 2017 | Original Story from American Society for Biochemistry and Molecular Biology.

 
How an Interest in Bipolar Disorder Drugs Led to a Better Understanding of Leukemia

A new project reveals that the enzyme GSK-3, a target of the mood disorder drug lithium, has a role in controlling alternative splicing in cells. This observation may yield insights into leukemia. Credit: Mansi Shinde and Simone Sidoli.

 
 
 

RELATED ARTICLES

Molecular Structure of Coronavirus Protein Marks "Critical" Step Towards Vaccine

News

In a new study published in the journal Science , researchers outline their work that could be considered a major step towards the development of a viable vaccine for the 2019 novel coronavirus. The work was deemed so pertinent that the journal Science expedited its review process for the study manuscript.

READ MORE

Why Representative Sampling Is Important

News

A new book introduces all the necessary concepts to develop the practical procedures needed and shows how a wide range of sampling scenarios can be tackled. This technical ability is, of course, critical for all of those responsible for sampling in the frontline and subsequent mass reduction.

READ MORE

Dementia Protein Stops Tau Being Cleared From the Brain

News

Researchers have identified a protein that increases the accumulation of neurotoxic tau tangles in the brain, which may pave the way to treatments that work by blocking this protein.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE